Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP

被引:102
作者
Young, Mark T. [1 ]
Pelegrin, Pablo [1 ]
Surprenant, Annmarie [1 ]
机构
[1] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
基金
英国惠康基金;
关键词
D O I
10.1124/mol.106.030163
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonist properties of the P2X(7) receptor (P2X(7)R) differ strikingly from other P2X receptors in two main ways: high concentrations of ATP (> 100 mu M) are required to activate the receptor, and the ATP analog 2', 3'-O-(4-benzoyl-benzoyl) ATP (BzATP) is both more potent than ATP and evokes a higher maximum current. However, there are striking species differences in these properties. We sought to exploit the large differences in ATP and BzATP responses between rat and mouse P2X(7)R to delineate regions or specific residues that may be responsible for the unique actions of these agonists at the P2X(7)R. We measured membrane currents in response to ATP and BzATP at wild-type rat and mouse P2X(7)R, at chimeric P2X(7)Rs, and at mouse P2X(7)Rs bearing point mutations. Wild-type rat P2X(7)R was 10 times more sensitive to ATP and 100 times more sensitive to BzATP than wild-type mouse P2X(7)R. We found that agonist EC50 values were determined solely by the ectodomain of the P2X(7)R. Two segments (residues 115-136 and 282-288), when transposed together, converted mouse sensitivities to those of rat. Point mutations through these regions revealed a single residue, asparagine(284), in the rat P2X(7)R that fully accounted for the 10-fold difference in ATP sensitivity, whereas the 100-fold difference in BzATP sensitivity required the transfer of both Lys(127) and Asn(284) from rat to mouse. Thus, single amino acid differences between species can account for large changes in agonist effectiveness and differentiate between the two widely used agonists at P2X(7) receptors.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 40 条
  • [1] Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor
    Adriouch, S
    Dox, C
    Welge, V
    Seman, M
    Koch-Nolte, F
    Haag, F
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (08) : 4108 - 4112
  • [2] Agonists and antagonists acting at P2X7 receptor
    Baraldi, PG
    Di Virgilio, F
    Romagnoli, R
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (16) : 1707 - 1717
  • [3] An antagonist-insensitive P-2X receptor expressed in epithelia and brain
    Buell, G
    Lewis, C
    Collo, G
    North, RA
    Surprenant, A
    [J]. EMBO JOURNAL, 1996, 15 (01) : 55 - 62
  • [4] A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes
    Cabrini, G
    Falzoni, S
    Forchap, SL
    Pellegatti, P
    Balboni, A
    Agostini, P
    Cuneo, A
    Castoldi, G
    Baricordi, OR
    Di Virgilio, F
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (01) : 82 - 89
  • [5] Identification of a trafficking motif involved in the stabilization and polarization of P2X receptors
    Chaumont, S
    Jiang, LH
    Penna, A
    North, RA
    Rassendren, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) : 29628 - 29638
  • [6] Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
    Chessell, IP
    Hatcher, JP
    Bountra, C
    Michel, AD
    Hughes, JP
    Green, P
    Egerton, J
    Murfin, M
    Richardson, J
    Peck, WL
    Grahames, CBA
    Casula, MA
    Yiangou, Y
    Birch, R
    Anand, P
    Buell, GN
    [J]. PAIN, 2005, 114 (03) : 386 - 396
  • [7] Effects of antagonists at the human recombinant P2X7 receptor
    Chessell, IP
    Michel, AD
    Humphrey, PPA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) : 1314 - 1320
  • [8] Cloning and functional characterisation of the mouse P2X7 receptor
    Chessell, IP
    Simon, J
    Hibell, AD
    Michel, AD
    Barnard, EA
    Humphrey, PPA
    [J]. FEBS LETTERS, 1998, 439 (1-2) : 26 - 30
  • [9] Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes
    Elliott, JI
    Surprenant, A
    Marelli-Berg, FM
    Cooper, JC
    Cassady-Cain, RL
    Wooding, C
    Linton, K
    Alexander, DR
    Higgins, CF
    [J]. NATURE CELL BIOLOGY, 2005, 7 (08) : 808 - U76
  • [10] The P2X7 receptor:: A key player in IL-1 processing and release
    Ferrari, Davide
    Pizzirani, Cinzia
    Adinolfi, Elena
    Lemoli, Roberto M.
    Curti, Antonio
    Idzko, Marco
    Panther, Elisabeth
    Di Virgilio, Francesco
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (07) : 3877 - 3883